期刊
AGE
卷 38, 期 4, 页码 303-322出版社
SPRINGER
DOI: 10.1007/s11357-016-9929-7
关键词
Aged; Alzheimer's disease; APP/PS1 mice; beta-amyloid; Hippocampal atrophy; Noncognitive abnormalities
资金
- National Natural Science Foundation of China [30971020, 30973517]
- Natural Science Foundation of Jiangsu Educational Department [09KJA310003]
Transgenic APPSwe/PS1dE9 (APP/PS1) mice that overproduce amyloid beta (A beta) are extensively used in the studies of pathogenesis and experimental therapeutics and new drug screening for Alzheimer's disease (AD). However, most of the current literature uses young or adult APP/PS1 mice. In order to provide a broader view of AD-like phenotype of this animal model, in this study, we systematically analyzed behavioral and pathological profiles of 24-month-old male APP/PS1 mice. Aged APP/PS1 mice had reference memory deficits as well as anxiety, hyperactivity, and social interaction impairment. Consistently, there was obvious deposition of amyloid plaques in the dorsal hippocampus with decreased expression of insulin-degrading enzyme, a proteolytic enzyme responsible for degradation of intracellular A beta. Furthermore, decreases in hippocampal volume, neuronal number and synaptophysin expression, and astrocyte atrophy were also observed in aged APP/PS1 mice. This finding suggests that aged APP/PS1 mice can well replicate cognitive and noncognitive behavioral abnormalities, hippocampal atrophy, and neuronal and astrocyte degeneration in AD patients, to enable more objective and refined preclinical evaluation of therapeutic drugs and strategies for AD treatment.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据